Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan S Lim

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Blood|December 1, 2018
PMBCL: a molecular diagnosis?Megan S Lim
British Journal of Haematology|August 22, 2023
Haematolymphoid malignancies: It is not important WHO we are but WHERE we go from hereMegan S Lim
Journal of Hematopathology|August 18, 2009
Commentary on the WHO 2008 classification of neoplasms arising from histiocytic and other accessory cellsMegan S Lim
Journal of Surgical Oncology|February 24, 2006
Re: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et alMegan S Lim
Blood|September 3, 2016
PDL structural rearrangements in B-cell NHLMegan S Lim
Blood|September 3, 2016
Targetable gene fusions in T-cell lymphomaMegan S Lim
Blood|March 21, 2009
Unraveling ALK signaling through phosphoproteomicsMegan S Lim
Frontiers in Oncology|October 9, 2023
Updates in pathobiological aspects of anaplastic large cell lymphomaRui Wu, Megan S Lim
Paediatric Drugs|May 23, 2013
Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to dateEric J Lowe, Megan S Lim
Journal of Hematopathology|August 12, 2009
T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summaryLindsay A Schmidt, Megan S Lim
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Blood|December 1, 2018
PMBCL: a molecular diagnosis?Megan S Lim
British Journal of Haematology|August 22, 2023
Haematolymphoid malignancies: It is not important WHO we are but WHERE we go from hereMegan S Lim
Journal of Hematopathology|August 18, 2009
Commentary on the WHO 2008 classification of neoplasms arising from histiocytic and other accessory cellsMegan S Lim
Journal of Surgical Oncology|February 24, 2006
Re: Correlational of oral tongue cancer inversion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression, by Kim S-H, Cho NH, Kim K, et alMegan S Lim
Blood|September 3, 2016
PDL structural rearrangements in B-cell NHLMegan S Lim
Blood|September 3, 2016
Targetable gene fusions in T-cell lymphomaMegan S Lim
Blood|March 21, 2009
Unraveling ALK signaling through phosphoproteomicsMegan S Lim
Frontiers in Oncology|October 9, 2023
Updates in pathobiological aspects of anaplastic large cell lymphomaRui Wu, Megan S Lim
Paediatric Drugs|May 23, 2013
Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to dateEric J Lowe, Megan S Lim
Journal of Hematopathology|August 12, 2009
T cell lymphoproliferative disorders associated with anti-tumor necrosis factor alpha antibody therapy for ulcerative colitis: literature summaryLindsay A Schmidt, Megan S Lim
Pageof 17